PARP-1 selectively impairs <em>KRAS</em>-driven phenotypic and molecular features in intrahepatic cholangiocarcinoma

CONCLUSION: Our findings identify the novel prognostic and therapeutic role of PARP-1 in iCCA patients with activation of oncogenic KRAS …